Synteract Competitors and Similar CompaniesClear all

Synteract's competitors and similar companies include Servier, Aurobindo Pharma, Glenmark Pharmaceuticals and USV.

	Synteract Synteract is a contract research organization that provides Phase I-IV services to biopharma companies.	Servier Servier, founded in 1954, is the first independent pharmaceutical group.	Aurobindo Pharma Aurobindo Pharma, a pharmaceutical company, manufactures and sells generic medicines to public and private health sectors in South Africa.	Glenmark Pharmaceuticals Glenmark Pharmaceuticals is a pharmaceutical company that develops and markets branded and generic formulations.	USV USV is a pharmaceutical and biotechnology company.
Founding Date	Founding Date 1986	Founding Date 1954	Founding Date 1986	Founding Date 1977	Founding Date 1961
Type	Type Private	Type Private	Type Public	Type Public	Type Private
Tags	Tags Healthcare biotech pharma	Tags Healthcare biotech pharma	Tags Healthcare biotech pharma	Tags Healthcare biotech pharma	Tags Healthcare biotech pharma
Locations	Locations Carlsbad, US HQ Wien, AT Brussel, BE München, DE Ciampino, IT Barcelona, ES Swansea, GB see more	Locations Suresnes, FR HQ Sidi M'hamed, DZ Yerevan, AM Hawthorn, AU Melbourne, AU Vienna, AT Baku, AZ see more	Locations Hyderabad, IN HQ Hyderabad, IN South Brunswick Township, US	Locations Mumbai, IN HQ Mumbai, IN	Locations Mumbai, IN HQ
Employees	Employees 1962% decrease	Employees 12,9983% increase	Employees 26,015	Employees 14,989	Employees 5,4971% increase
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) ₹333.8b (FY, 2026)	Revenue (est.) ₹131.5b (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods ₹134.9b (FY, 2026)	Cost of goods ₹46.7b (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit N/A	Gross profit ₹206.6b (FY, 2026)	Gross profit ₹87b (FY, 2025)	Gross profit N/A
Net income	Net income N/A	Net income N/A	Net income ₹35b (FY, 2026)	Net income ₹10.5b (FY, 2025)	Net income N/A